Cite
HARVARD Citation
López-Neyra, A. et al. (2020). Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial. Prostaglandins, leukotrienes, and essential fatty acids. p. . [Online].